NCT06850038View on ClinicalTrials.gov

A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 22, 2025

Primary Completion Date

November 30, 2029

Study Completion Date

November 30, 2029

Conditions
Alagille Syndrome
Trial Locations (2)

10016

RECRUITING

NYU Langone - NYU Grossman School of Medicine, New York

79902

RECRUITING

Proactive El Paso,LLC, El Paso

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY